Stock Evaluator: Savara Inc. (SVRA)

Savara Inc. SVRA

$4.55 -0.10 -2.05%
November 16, 2026 11:46:30 AM EST November 10, 2021 Volume: 911,873
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.

Commentary & Analysis


Financial Summary

Share Statistics SVRA Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,249.6 $211.8 49%
Shares Out (Mil) 254.2 55.4 80%
Institutional Ownership 96.6% 93.0% 70%
Float (Mil) 144.9 41.5 68%
Beta 0.30 0.99 17%
Avg Daily Volume (000s) 3,350 553 87%
Price Change
(52-week)
12.6% 42.8% 63%
Growth SVRA Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.2% na
Net Income (5yr) (19.1%) (10.3%) 21%
EPS (5yr) 8.2% 15.8% 44
Dividends (5yr) na 0.0% na
Cash Flow (5yr) 16.9% (15.7%) 76%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 5 6 5
Current EPS ($0.167) ($0.643) ($0.336)
Month Ago EPS ($0.166) ($0.649) ($0.367)
# Rev Up 0 1 0
# Rev Down 1 0 1
Three Months Ago EPS ($0.150) ($0.616) ($0.312)
Year/Year Chg (1.2%) 20.4% (115.4%)
Financials SVRA Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $41 na
Net Income (TTM) (Mil) ($153) ($44) 8%
EPS (TTM) ($0.610) ($1.500) 25%
Operating Cash Flow (TTM) (Mil) ($130) ($35) 5%
Net Cash Flow (TTM) (Mil) $14 $-0 60%
Long-Term Debt (Q1) (Mil) $32 $4 35%
Enterprise Value (Q1) (Mil) $1,225 $147 44%
Valuation SVRA Industry
Median
Percentile
(All Stocks)
P/B 11.05 2.01 93%
P/E na 17.9 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.0 na
Ratios SVRA Industry
Median
Percentile
(All Stocks)
Gross Margin na 67.9% na
Net Margin na (50.6%) na
ROA (102.9%) (47.4%) 5%
ROE (151.0%) (53.1%) 6%
Liabilities to Assets 30.8% 29.7% 22%
F-Score 2 3 7%

Savara Inc. did not pass any screens on 11/13/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors